Isikoglu M - Search Results

1

Modified natural protocol seems superior to natural and artificial protocols for preparing the endometrium in frozen embryo transfer cycles.

Isikoglu M, Aydinuraz B, Avci A, Kendirci Ceviren A. Isikoglu M, et al. Minerva Ginecol. 2020 Aug;72(4):195-201. doi: 10.23736/S0026-4784.20.04570-0. Epub 2020 May 13. Minerva Ginecol. 2020. PMID: 32403918

2

Endometrial polyps smaller than 1.5 cm do not affect ICSI outcome.

Isikoglu M, Berkkanoglu M, Senturk Z, Coetzee K, Ozgur K. Isikoglu M, et al. Reprod Biomed Online. 2006 Feb;12(2):199-204. doi: 10.1016/s1472-6483(10)60861-9. Reprod Biomed Online. 2006. PMID: 16478585

3

Flushing the endometrium prior to the embryo transfer does not affect the pregnancy rate.

Berkkanoglu M, Isikoglu M, Seleker M, Ozgur K. Berkkanoglu M, et al. Among authors: isikoglu m. Reprod Biomed Online. 2006 Aug;13(2):268-71. doi: 10.1016/s1472-6483(10)60625-6. Reprod Biomed Online. 2006. PMID: 16895645 Clinical Trial.

4

What is the best time to perform intracytoplasmic sperm injection/embryo transfer cycle after hysteroscopic surgery for an incomplete uterine septum?

Berkkanoglu M, Isikoglu M, Arici F, Ozgur K. Berkkanoglu M, et al. Among authors: isikoglu m. Fertil Steril. 2008 Dec;90(6):2112-5. doi: 10.1016/j.fertnstert.2007.10.018. Epub 2008 Jan 4. Fertil Steril. 2008. PMID: 18177864 Free article.

5

Conventional IVF revisited: Is ICSI better for non-male factor infertility? Randomized controlled double blind study.

Isikoglu M, Avci A, Kendirci Ceviren A, Aydınuraz B, Ata B. Isikoglu M, et al. J Gynecol Obstet Hum Reprod. 2021 Sep;50(7):101990. doi: 10.1016/j.jogoh.2020.101990. Epub 2020 Nov 19. J Gynecol Obstet Hum Reprod. 2021. PMID: 33221561 Clinical Trial.

6

Comparison of ICSI and conventional IVF in non-male factor patients with less than four oocytes.

Isikoglu M, Ceviren AK, Cetin T, Avci A, Aydinuraz B, Akgul OK, Karaca M. Isikoglu M, et al. Arch Gynecol Obstet. 2022 Aug;306(2):493-499. doi: 10.1007/s00404-022-06471-x. Epub 2022 Feb 27. Arch Gynecol Obstet. 2022. PMID: 35224650

7

Bone resorption starts at 14 days of treatment with gonadotropin-releasing hormone agonist in in vitro fertilization cycles.

Yilmaz H, Ozgur K, Isikoglu M, Sonmez C, Uner M. Yilmaz H, et al. Among authors: isikoglu m. Gynecol Endocrinol. 2004 Jul;19(1):40-6. doi: 10.1080/09513590410001729185. Gynecol Endocrinol. 2004. PMID: 15625772 Free article.

8

Extension of GnRH agonist through the luteal phase to improve the outcome of intracytoplasmic sperm injection.

Isikoglu M, Ozgur K, Oehninger S. Isikoglu M, et al. J Reprod Med. 2007 Jul;52(7):639-44. J Reprod Med. 2007. PMID: 17847764 Clinical Trial.

9

Rapid decline in ovarian reserve after repeated ART cycles in a 22-year-old IVF patient.

Isikoglu M, Ozgur K. Isikoglu M, et al. Arch Gynecol Obstet. 2003 Aug;268(3):206-8. doi: 10.1007/s00404-003-0523-8. Epub 2003 Jun 25. Arch Gynecol Obstet. 2003. PMID: 12827391

10

Clinical effects of ovulation induction with recombinant follicle-stimulating hormone supplemented with recombinant luteinizing hormone or low-dose recombinant human chorionic gonadotropin in the midfollicular phase in microdose cycles in poor responders.

Berkkanoglu M, Isikoglu M, Aydin D, Ozgur K. Berkkanoglu M, et al. Among authors: isikoglu m. Fertil Steril. 2007 Sep;88(3):665-9. doi: 10.1016/j.fertnstert.2006.11.150. Epub 2007 Feb 12. Fertil Steril. 2007. PMID: 17292895 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

33 results

Search Page

Filters